Insights from SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to 13th, 2024 at the Henry B. Gonzalez Convention Center in San Antonio, TX, USA.
SABCS is expected to attract around 10,000+ attendees from more than 102 countries, including oncologists, researchers, and healthcare professionals.
This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancerand premalignant breast disease to an international audience of academic and private physicians and researchers.
Welcome to the 47th annual San Antonio Breast Cancer Symposium
“Symposium co-directors Virginia Kaklamani and Carlos L. Arteaga welcome attendees to the 47th annual San Antonio Breast Cancer Symposium.”
“Sarah McLaughlin, Yvonne Florance, Stephanie Wong, and Atif Khan discussed ‘Optimizing Local Therapy’ in an SABCS24 educational session moderated by Tari King.”
Axillary staging in ER-positive breast cancer
“Monica Morrow, MD, will moderate an SABCS24 session about axillary staging in ER-positive breast cancer on Thursday. Learn more in SABCS Meeting News.”
Future Directions in Antibody Drug Conjugates
“Future Directions in Antibody Drug Conjugates: John Lambert, Giuseppe Curigliano, Ingrid Mayer, and Paolo Tarantino addressed this topic in the SABCS24 People’s Choice Educational Session.”
“Christina Curtis, the 2024 recipient of the AACR Outstanding Investigator Award for Breast Cancer Research, delivered her award lecture this evening at SABCS.”
The Winding Road of Immune Biomarkers in Early Breast Cancer
“Roberto Salgado, Justin Balko, and Priyanka Sharma (who joined virtually) explored ‘The Winding Road of Immune Biomarkers in Early Breast Cancer’ in a State of the Art Session moderated by Sherene Loi.”
Tumor Agnostic Drug Development
“Tumor Agnostic Drug Development: Funda Meric and Fabrice Andre addressed this topic in a Translational Controversies session at SABCS24.”
How to Define Triple Negative Breast Cancer
“Rebecca Dent and Charles Perou debated ‘How to Define Triple Negative Breast Cancer’ in a Translational Controversies session at SABCS24.”
Enjoy the experiences of SABCS24 attendees
“Enjoy the experiences of SABCS24 attendees and share your own— Visit the SABCS Meeting News photo gallery.”
Results of several phase 2 and 3 clinical trials
“Moderators Alexandra Thomas and Reshma Mahtani welcome SABCS24 attendees to today’s General Session. The session showcases the results of several phase 2 and 3 clinical trials, including EMBER-3, PHILA, and OlympiA.”
Highlights from Day 1 of SABCS 2024.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023